Viral recombinant vectors for expression in muscle cells
US6743623B2 · kind B2 · utility
2Cited by
3References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 6, 1999 |
| Grant date | Jun 1, 2004 |
| Priority date | — |
| Expiry date | Dec 6, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2710/10343
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Non-replicable viral recombinant vectors which are recognizable by muscle cell receptors, and furthermore modified by an inserted nucleic acid coding for a polypeptide sequence to be expressed in the muscle cells, are used to obtain a composition for treating muscle cell diseases or disease which, by virtue of their location in the body are accessible to the production of expression. A method for producing said vectors and their use in pharmaceutical compositions are also described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.